Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-dose growth hormone study in children with growth hormone deficiency
NL-OMON29520Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Aug 1987
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Novo Nordisk. Primary endpoints: Adult height and Attained adult height minus target height. Started Aug 1987; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NL-OMON29520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29520.